TCAR与CEA术后三年卒中风险比较
基于VISION数据库链接Medicare理赔数据,回顾性比较TCAR与CEA术后3年卒中风险。无症状和有症状患者中,TCAR与CEA的3年卒中风险均相似,但TCAR的卒中或死亡复合风险更高。
要点
- 无症状患者TCAR与CEA的3年卒中风险相似(5.1% vs 4.9%)。
- 有症状患者TCAR与CEA的3年卒中风险亦相似(16.6% vs 13.6%)。
- TCAR组卒中或死亡复合风险在无症状和有症状患者中均高于CEA。
核心结论
- TCAR与CEA术后3年卒中风险相似,且在无症状和有症状患者中一致。
研究设计与样本
- 回顾性队列研究,使用VISION注册数据库链接Medicare理赔数据,纳入2016年10月1日至2019年12月31日期间接受TCAR或CEA的患者。
主要发现
- 无症状患者3年卒中风险:TCAR 5.1%(95% CI 3.0%-7.1%),CEA 4.9%(95% CI 4.4%-5.4%),log-rank P = .93。
- 无症状患者3年卒中或死亡复合风险:TCAR 22.6%(95% CI 18.8%-26.3%),CEA 20.0%(95% CI 18.8%-21.2%),log-rank P < .001。
- 有症状患者3年卒中风险:TCAR 16.6%(95% CI 12.1%-20.9%),CEA 13.6%(95% CI 12.5%-14.7%),log-rank P = .17。
- 有症状患者3年卒中或死亡复合风险:TCAR 35.9%(95% CI 30.1%-41.2%),CEA 30.0%(95% CI 28.3%-31.7%),log-rank P < .001。
- 调整后卒中风险比:无症状患者TCAR vs CEA HR 1.10(95% CI 0.82-1.49);有症状患者HR 1.00(95% CI 0.75-1.33)。
临床怎么用
- TCAR与CEA术后3年卒中风险相似,可为患者和医生选择颈动脉手术方式及共享决策提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcarotid artery revascularization (TCAR) has seen widespread adoption in contemporary practice. However, the risk of stroke after TCAR vs carotid endarterectomy (CEA) beyond the perioperative period remains poorly defined. Our objective was to compare the 3-year risk of stroke after TCAR vs CEA. METHODS: We performed a retrospective cohort study using data from the Vascular Implant Surveillance and Outcomes Network (VISION), a procedural registry linked to Medicare claims data that captures clinical, procedural, and outcomes data on patients who underwent carotid revascularization. We studied patients who underwent TCAR or CEA and were part of the VISION database between October 1, 2016 (start of TCAR surveillance registry), and December 31, 2019 (end of linked Medicare claims availability). The primary exposure was surgery type (TCAR or CEA). The primary outcome was stroke, defined using a validated claims code list, and death. Asymptomatic and symptomatic patients were analyzed separately. We used Kaplan-Meier analysis and Cox regression for risk adjustment. We used competing-risk and propensity score methods for sensitivity analyses. RESULTS: There were 19,141 asymptomatic (TCAR, 3482; CEA, 15,659) and 12,343 symptomatic (TCAR, 2 377; CEA, 9966) patients who underwent carotid surgery. Patients who underwent TCAR were older, more likely to be female, and more likely to be anatomical high risk. Among asymptomatic patients, the 3-year risk of stroke was similar after TCAR (5.1%; 95% CI, 3.0%-7.1%) and CEA (4.9%; 95% CI, 4.4%-5.4%; log-rank P = .93). The composite 3-year risk of stroke or death was 22.6% (95% CI, 18.8%-26.3%) after TCAR and 20.0% (95% CI, 18.8%-21.2%) after CEA (log-rank P < .001). Compared with CEA, the adjusted HR of stroke after TCAR among asymptomatic patients was 1.10 (95% CI, 0.82-1.49). Among patients with symptomatic carotid stenosis, the 3-year risk of stroke was also similar between TCAR (16.6%; 95% CI, 12.1%-20.9%) and CEA (13.6%; 95% CI, 12.5%-14.7%; log-rank P = .17). The composite 3-year risk of stroke or death risk was 35.9% (95% CI, 30.1%-41.2%) after TCAR and 30.0% (95% CI, 28.3%-31.7%) after CEA (log-rank P < .001). Compared with CEA, the adjusted HR for stroke after TCAR among symptomatic patients was 1.00 (95% CI, 0.75-1.33). CONCLUSIONS: In this comparative effectiveness study, TCAR had a similar risk of stroke to CEA. This was durable over 3 years of follow-up and was consistent among asymptomatic and symptomatic patients. These results can inform procedure choices for patients and providers when considering carotid surgery and help to inform requisite shared decision-making before intervention.
引用
- Columbo JA, Martinez-Camblor P, Stone DH, et al. Three-year risk of stroke after transcarotid artery revascularization versus carotid endarterectomy among Medicare beneficiaries. J Vasc Surg. 2025. PMID: 40653125. doi:10.1016/j.jvs.2025.06.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。